DEPO-MEDROL Drug Patent Profile
✉ Email this page to a colleague
When do Depo-medrol patents expire, and when can generic versions of Depo-medrol launch?
Depo-medrol is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in DEPO-MEDROL is methylprednisolone acetate. There are forty drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Depo-medrol
A generic version of DEPO-MEDROL was approved as methylprednisolone acetate by HONG KONG on February 23rd, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEPO-MEDROL?
- What are the global sales for DEPO-MEDROL?
- What is Average Wholesale Price for DEPO-MEDROL?
Summary for DEPO-MEDROL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Clinical Trials: | 122 |
| Patent Applications: | 4,456 |
| Drug Prices: | Drug price information for DEPO-MEDROL |
| Drug Sales Revenues: | Drug sales revenues for DEPO-MEDROL |
| What excipients (inactive ingredients) are in DEPO-MEDROL? | DEPO-MEDROL excipients list |
| DailyMed Link: | DEPO-MEDROL at DailyMed |
See drug prices for DEPO-MEDROL
Recent Clinical Trials for DEPO-MEDROL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Zheng Liu | N/A |
| Brii Biosciences Limited | Phase 2 |
| Emory University | Phase 4 |
Pharmacology for DEPO-MEDROL
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for DEPO-MEDROL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | DEPO-MEDROL | methylprednisolone acetate | INJECTABLE;INJECTION | 011757-002 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | DEPO-MEDROL | methylprednisolone acetate | INJECTABLE;INJECTION | 011757-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pfizer | DEPO-MEDROL | methylprednisolone acetate | INJECTABLE;INJECTION | 011757-004 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
